Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment. For more information, please visit www.aglaia-oncology.com
View Top Employees from Aglaia Oncology Funds| Website | http://www.aglaia-oncology.com |
| Revenue | $1 million |
| Employees | 7 (4 on RocketReach) |
| Founded | 2003 |
| Address | Businesspark Berg En Bosch 10 building 92 Prof. Bronkhorstlaan, Bilthoven 3723, NL |
| Phone | +31 30 229 6090 |
| Industry | Biotechnology Research, Venture Capital & Private Equity, Finance |
| SIC | SIC Code 6799 Companies, SIC Code 679 Companies, SIC Code 67 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies |
Looking for a particular Aglaia Oncology Funds employee's phone or email?
Aglaia Oncology Funds Questions
The Aglaia Oncology Funds annual revenue was $1 million in 2023.
Karl Rothweiler is the Managing Partner of Aglaia Oncology Funds.
4 people are employed at Aglaia Oncology Funds.
The NAICS codes for Aglaia Oncology Funds are [541, 54171, 54, 5417, 541711].
The SIC codes for Aglaia Oncology Funds are [6799, 679, 67].
Top Aglaia Oncology Funds Employees
-
2
-
35+
-
54
Related Companies
